Oncology & Cancer
Transplant medication matters for controlling cancer risk
Research reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppressant medication.
Aug 1, 2018
0
0
OncoImmunology
Oncology & Cancer
Immune cells localized near pancreatic cancer cells have altered metabolism, could promote cancer
A diagnosis of pancreatic cancer is a virtual death sentence, with only 3 to 5 per cent of patients surviving beyond five years. A key reason that it has the lowest survival rate of all major cancers is that it readily spreads ...
May 9, 2017
0
1
Oncology & Cancer
Repurposing COVID‑19 immune response for cancer therapy
COVID-19 has touched almost every country around the world since it emerged months ago. As of September 9, 2020, 27.6 million people have been infected with the SARS-CoV-2 virus, and there have been 898,000 deaths. But, a ...
Sep 15, 2020
0
8
Oncology & Cancer
New potential for personalized treatments in bowel cancer
Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today in the journal Oncoimmunology.
Mar 22, 2015
0
15
Oncology & Cancer
Inhibited Tyk2 retains anti-cancer activity
Tyrosine kinase 2 (Tyk2) is an enzyme involved in intracellular signalling and has an important role in activating the immune system. But enzymatically active Tyk2 can also promote excessive immune reactions and growth of ...
Sep 11, 2015
0
9
Immunology
Circulating small cell lung cancer cells successfully cultivated for the very first time
Most cases of small cell lung cancer are only diagnosed after the tumour has already formed metastases. Until now it has not been possible to investigate the reasons for this rapid metastasis, because of a lack of sufficient ...
Nov 19, 2015
0
14
Oncology & Cancer
Researchers develop advanced cell screening technology for cancer immunotherapy
Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for ...
Aug 10, 2015
0
24
Oncology & Cancer
New mechanism activates the immune system against tumour cells
The body's defences detect and eliminate not only pathogens but also tumour cells. Natural killer cells (NK-Cells) are specifically activated by chemical messengers, the Cytokines, to seek and destroy tumour cells. Veronika ...
Jun 17, 2016
0
1
Oncology & Cancer
Researchers develop new anticancer peptide vaccines and inhibitors
(Medical Xpress)—Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort led by investigators at The Ohio State University Comprehensive ...
Sep 24, 2014
0
0
Oncology & Cancer
Blood-based biomarkers for brain tumours
Researchers at the Indian Institute of Science (IISc), along with collaborators, have identified potential blood-based biomarkers to predict disease progression and survival times in those with late-stage brain tumors.
Nov 18, 2021
0
4
